Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
Michael Brines(Northwell Health), Anthony Cerami(Araim Pharmaceuticals (United States)), Massimiliano De Paola(Mario Negri Institute for Pharmacological Research), Zübeyde Erbayraktar, Michael Yamin, Pietro Ghezzi(Brighton and Sussex Medical School), Nimesh S. A. Patel(William Harvey Research Institute), Courtenay M. Brines, Tiziana Mennini(Mario Negri Institute for Pharmacological Research), Pia Villa, Thomas R. Coleman(University of Messina), Bruno Sepodes(University of Lisbon), Serhat Erbayraktar(University of Messina), Qiao-wen Xie(University of Messina), Christoph Thiemermann(Queen Mary University of London)
Cited by 323
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Mesenchymal Stromal Cells: Current Understanding and Clinical Status
|Stem Cells|2009|921
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906